Gowetski DB - Search Results

Year	Number of Results
2013	1
2020	2
2021	8
2022	5
2023	4
2024	2
2025	0

1

Tyrosine O-sulfation proteoforms affect HIV-1 monoclonal antibody potency.

Cai CX, Doria-Rose NA, Schneck NA, Ivleva VB, Tippett B, Shadrick WR, O'Connell S, Cooper JW, Schneiderman Z, Zhang B, Gowetski DB, Blackstock D, Demirji J, Lin BC, Gorman J, Liu T, Li Y, McDermott AB, Kwong PD, Carlton K, Gall JG, Lei QP. Cai CX, et al. Among authors: gowetski db. Sci Rep. 2022 May 19;12(1):8433. doi: 10.1038/s41598-022-12423-x. Sci Rep. 2022. PMID: 35589938 Free PMC article.

2

Quantitation of strain-specific hemagglutinin trimers in mosaic quadrivalent influenza nanoparticle vaccine by ELISA.

Alabanza C, Gavrilov V, Scott T, Yang RS, Gowetski DB, Gall JG, Paula Lei Q. Alabanza C, et al. Among authors: gowetski db. Vaccine. 2023 Aug 7;41(35):5201-5210. doi: 10.1016/j.vaccine.2023.07.009. Epub 2023 Jul 12. Vaccine. 2023. PMID: 37451877

3

Quantification of prefusion conformation for HIV vaccine using size-exclusion chromatography.

Gollapudi D, Shadrick W, Yang Y, Gowetski DB, Gall J, Paula Lei Q. Gollapudi D, et al. Among authors: gowetski db. J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Jun 30;1201-1202:123296. doi: 10.1016/j.jchromb.2022.123296. Epub 2022 May 13. J Chromatogr B Analyt Technol Biomed Life Sci. 2022. PMID: 35598458

4

Advances in purification of SARS-CoV-2 spike ectodomain protein using high-throughput screening and non-affinity methods.

Cibelli N, Arias G, Figur M, Khayat SS, Leach K, Loukinov I, Shadrick W, Chuenchor W, Tsybovsky Y; Vaccine Production Program Analytical Development; Gulla K, Gowetski DB. Cibelli N, et al. Among authors: gowetski db. Sci Rep. 2022 Mar 15;12(1):4458. doi: 10.1038/s41598-022-07485-w. Sci Rep. 2022. PMID: 35292666 Free PMC article.

5

Analytical characterization of broadly neutralizing antibody CAP256LS heavy chain clipping during manufacturing development.

Gollapudi D, Rosales-Zavala E, Ivleva VB, Yang Y, Li Y, O'Connell S, Doria-Rose NA, Patel A, Blackstock D, Gowetski DB, Carlton K, Gall JGD, Lei QP. Gollapudi D, et al. Among authors: gowetski db. Biotechnol Prog. 2022 Nov;38(6):e3296. doi: 10.1002/btpr.3296. Epub 2022 Aug 29. Biotechnol Prog. 2022. PMID: 36054677

6

Site-Specific Fluorescent Labeling of Hemagglutinin-Specific Antigen Binding Fragment through Amine Chemistry Revealed by Mass Spectrometry.

Zou G, Ivleva VB, Wolff JJ, Yang RS, Alabanza C, Barefoot N, Cai C, Yang Y, Gowetski DB, Gall JG, Lei QP. Zou G, et al. Among authors: gowetski db. J Am Soc Mass Spectrom. 2023 May 3;34(5):813-819. doi: 10.1021/jasms.2c00330. Epub 2023 Mar 31. J Am Soc Mass Spectrom. 2023. PMID: 37000420

7

Development and application of an analytical approach to assess an antibody's potential for disulfide reduction.

Yang Y, Bastani N, Lagler SK, Harris D, Nagy A, Chen P, Patel A, Li Y, Gowetski DB, Lei QP. Yang Y, et al. Among authors: gowetski db. Biotechnol Prog. 2022 Mar;38(2):e3229. doi: 10.1002/btpr.3229. Epub 2022 Jan 9. Biotechnol Prog. 2022. PMID: 34962716

8

Development of a RPLC-UV method for monitoring uncleaved HIV-1 envelope glycoprotein.

Schneck NA, Vinitsky AL, Ivleva VB, Wang X, Gowetski DB, Lei QP. Schneck NA, et al. Among authors: gowetski db. Anal Methods. 2021 May 21;13(19):2183-2188. doi: 10.1039/d1ay00072a. Epub 2021 May 6. Anal Methods. 2021. PMID: 33954330 Free PMC article.

9

Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine.

Casazza JP, Hofstetter AR, Costner PJM, Holman LA, Hendel CS, Widge AT, Wu RL, Whalen WR, Cunningham J, Arthur A, Wang X, Ola A, Saunders J, Mendoza F, Novik L, Burgos Florez MC, Ortega-Villa AM, Apte PJ, Strom L, Wang L, Imam M, Basappa M, Naisan M, Castro M, Trost JF, Narpala SR, Vanderven HA, Yamshchikov GV, Berkowitz NM, Gordon IJ, Plummer SH, Wycuff DL, Vazquez S, Gillespie RA, Creanga A, Adams WC, Carlton K, Gall JG, McDermott AB, Serebryannyy LA, Houser KV, Koup RA, Graham BS, Ledgerwood JE, Mascola JR, Pierson TC, Andrews SF, Kanekiyo M, Dropulic LK; VRC 323 study team. Casazza JP, et al. NPJ Vaccines. 2024 Sep 17;9(1):171. doi: 10.1038/s41541-024-00959-0. NPJ Vaccines. 2024. PMID: 39289377 Free PMC article.

10

Characterization of Flu MOSAIC nanoparticle vaccine candidate using high performance size-exclusion chromatography to support vaccine process development.

Sylvie Yang R, Yang Y, Gowetski DB, Tsybovsky Y, Gall JGD, Paula Lei Q. Sylvie Yang R, et al. Among authors: gowetski db. Vaccine. 2023 Apr 6;41(15):2534-2545. doi: 10.1016/j.vaccine.2023.03.001. Epub 2023 Mar 9. Vaccine. 2023. PMID: 36906406

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year